Page last updated: 2024-08-25
rilmenidine and ALS - Amyotrophic Lateral Sclerosis
rilmenidine has been researched along with ALS - Amyotrophic Lateral Sclerosis in 2 studies
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Cuic, B; Luikinga, SJ; Perera, ND; Rytova, V; Tomas, D; Turner, BJ; Wanniarachchillage, N | 1 |
Beart, PM; Horne, MK; Lau, CL; Perera, ND; Sheean, RK; Shin, YS; Turner, BJ | 1 |
Other Studies
2 other study(ies) available for rilmenidine and ALS - Amyotrophic Lateral Sclerosis
Article | Year |
---|---|
Stimulation of mTOR-independent autophagy and mitophagy by rilmenidine exacerbates the phenotype of transgenic TDP-43 mice.
Topics: Amyotrophic Lateral Sclerosis; Animals; Antihypertensive Agents; Autophagy; DNA-Binding Proteins; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mitophagy; Phenotype; Rilmenidine; TOR Serine-Threonine Kinases | 2021 |
Rilmenidine promotes MTOR-independent autophagy in the mutant SOD1 mouse model of amyotrophic lateral sclerosis without slowing disease progression.
Topics: Amyotrophic Lateral Sclerosis; Animals; Autophagy; Disease Models, Animal; DNA-Binding Proteins; Humans; Mice, Transgenic; Motor Neurons; Rilmenidine; Superoxide Dismutase-1; TOR Serine-Threonine Kinases | 2018 |